da Silva Jaiurte Gomes Martins, de Melo Ismaela Maria Ferreira, Alves Érique Ricardo, de Oliveira Glícia Maria, da Silva Anderson Arnaldo, Cavalcanti Isabela Macário Ferro, Araujo Diego Neves, Pinto Flávia Cristina Morone, de Andrade Aguiar José Lamartine, Wanderley Teixeira Valéria, Coelho Teixeira Álvaro Aguiar
Graduate Program of Animal Bioscience, Department of Animal Morphology and Physiology, Federal Rural University of Pernambuco, Recife 52171-900, PE, Brazil.
Department of Medicine, Federal University of Alagoas, Arapiraca 57309-005, AL, Brazil.
Polymers (Basel). 2024 Sep 15;16(18):2611. doi: 10.3390/polym16182611.
The poor healing of diabetic wounds is characterized by prolonged inflammation and decreased collagen deposition. Diabetic patients exhibit changes in the plasma concentrations of pro-inflammatory cytokines, and the role of specific dressings may have an impact on healing. This study aims to evaluate the effects of a combined treatment comprising a bacterial cellulose dressing and melatonin application on the regulation and expression of inflammatory cytokines, VEGF, PCNA, and collagen in the healing of cutaneous wounds of diabetic rats. Pro-inflammatory cytokines, including IL-6, TNF-α, and VEGF, along with PCNA and type I and III collagen, were evaluated after 14 days. Immunohistochemistry showed decreased levels of IL-6, TNF-α, and VEGF, along with an increased expression of PCNA and type I collagen, in the groups treated exclusively with melatonin and bacterial cellulose associated with melatonin compared to the control and the commercial healing agent. It was concluded that treating the skin lesions of diabetic animals supplemented with melatonin using a bacterial cellulose-based dressing has positive effects in regulating the expression of inflammatory cytokines, vascular endothelial growth factor, and collagen, showing that this association could be a viable therapy approach in wound healing.
Biochim Biophys Acta. 2014-1
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2024-4-20
Chem Biol Interact. 2020-6-15
Front Endocrinol (Lausanne). 2025-7-4
Rev Col Bras Cir. 2023
Eur J Pharmacol. 2022-12-5
Drug Discov Today. 2022-4
Pharmaceutics. 2021-9-30
Mater Sci Eng C Mater Biol Appl. 2021-9